匯川技術(300124.SZ):與潛在客户一起把匯川的執行器技術在人形核心部件領域進行遷移和性能打磨
格隆匯4月1日丨匯川技術(300124.SZ)在投資者互動平台表示,公司對人形機器人產業的相關佈局尚處於早期洞察與研究階段,人形機器人關節核心零部件與工業自動化主航道領域的技術基礎同源,例如運動控制、伺服驅動、電機技術,直線驅動等,後續會做好產業鏈的跟蹤與洞察,並與潛在客户一起把匯川的執行器技術在人形核心部件領域進行遷移和性能打磨。2023年,根據第三方數據,公司工業機器人業務在國內出貨量排名第四,SCARA機器人出貨量國內排名第一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.